The Effects of Oral Administration of Lactobacillus Plantarum WCFS1, Lactobacillus Plantarum CIP104448, and Lactobacillus Plantarum CIP104450 on Small Intestinal Mucosa and Barrier Function
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Lactobacillus plantarum (Primary)
- Indications Inflammatory bowel diseases
- Focus Pharmacodynamics
- 19 Jul 2012 Biomarkers information updated
- 18 Jul 2012 Actual end date (Apr 2012) added as reported by ClinicalTrials.gov.
- 18 Jul 2012 Actual initiation date (Oct 2011) added as reported by ClinicalTrials.gov.